| Literature DB >> 21967896 |
Ai Tada1, Akira Shimada, Taketo Yamada, Yoichi Oikawa, Yoshifumi Yamada, Yoshiaki Okubo, Junichiro Irie, Jeffrey A Bluestone, Hiroshi Itoh.
Abstract
Human fulminant type 1 diabetes (FT1D) is an extremely aggressive disease. The delay of proper diagnosis results in high mortality. However, the pathophysiology of this disease remains unclear. We took advantage of CD28-deficient NOD (CD28(-/-) NOD) mice, which have limited numbers of regulatory T cells and develop aggressive autoimmune diabetes, to create a FT1D model that mimicked the disease in humans. Young CD28(-/-) NOD mice were injected with polyinosinic-polycytidylic acid to activate innate immunity in an effort to induce diabetes onset. In this model, innate immune cell activation precedes the onset of diabetes similar to ∼70% of FT1D patients. Eighty-three percent of CD28(-/-) NOD mice developed diabetes within 1-6 d after injection of polyinosinic-polycytidylic acid. Moreover, T cells infiltrated the pancreatic exocrine tissue and destroyed α cells, an observation characteristic of human FT1D. We conclude that an FT1D-like phenotype can be induced in the background of autoimmune diabetes by a mimic of viral dsRNA, and this model is useful for understanding human FT1D.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21967896 DOI: 10.4049/jimmunol.1000837
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422